{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-062803","form_type":"8-K","ticker":"RLMD","cik":"0001553643","company_name":"RELMADA THERAPEUTICS, INC.","filed_at":"2025-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.313265+00:00","generated_at":"2026-05-18T08:44:25.074526+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Relmada terminates esmethadone license agreement with Inturrisi and Manfredi","bullets":["On July 7, 2025, Relmada delivered termination notice for the esmethadone License Agreement with Drs. Inturrisi and Manfredi.","The agreement granted exclusive worldwide license for esmethadone in psychiatric use; obligations cease 90 days after notice.","Relmada had been paying $45,000 quarterly under the agreement; upfront fee of $180,000 paid in 2018.","The termination ends Relmada's participation in the previously announced esmethadone development program.","No commercial sales, royalties, or sublicense payments had occurred under the agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-062803","json":"https://secwatch.observer/filing/0001213900-25-062803.json","markdown":"https://secwatch.observer/filing/0001213900-25-062803.md","text":"https://secwatch.observer/filing/0001213900-25-062803.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025062803/0001213900-25-062803-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025062803/ea0248503-8k_relmada.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:44:25.074526+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}